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Abstract21
There is an epidemiological association between periodontitis and rheumatoid arthritis (RA),22
hypothesised to lead to enhanced generation of RA-related autoantibodies, which can be23
detected years before the onset of RA symptoms. Periodontitis is a common dysbiotic24
disease; tissue damage occurs because the immune system fails to limit both the resident25
microbial community and the associated local immune response. Certain periodontal26
bacteria, including Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans,27
may contribute to RA-autoantibody production through direct post-translational modification28
of proteins or, indirectly, by influencing neutrophil-mediated neo-epitope generation. Oral29
bacteria that invade the blood may also contribute to chronic inflammatory responses and30
generation of autoantibodies. The putative association between periodontitis and the31
development of RA raises the potential of finding novel predictive markers of disease and32
disease progression, and for periodontitis treatment to be included in the future as an adjunct33
to conventional RA immunotherapy or as part of a preventive strategy.34
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3Introduction41
Rheumatoid arthritis (RA) is a systemic autoimmune disease that manifests as a chronic42
polyarthritis. There is increasing evidence that the initiating events that result in the43
generation of RA-related autoantibodies, which can be detected years before the onset of RA44
symptoms, occur at mucosal sites distant to the joints [1-5]. Inflammatory processes in45
response to environmental triggers, including infections, in the lungs and the mouth have46
been strongly implicated and, recently, also in the gastrointestinal and genitourinary tracts47
[4-7]. This review concentrates on the contribution of oral disease, specifically periodontal48
disease, and oral bacteria to the development of RA.49
Periodontal diseases are common oral inflammatory conditions that occur in response to50
bacterial plaque biofilms, causing damage to the gingivae (gums), periodontal ligament and51
alveolar bone, all of which form the supporting tissues of the teeth (Figure). Severe52
periodontitis occurs in 2-20% of most adult populations, affecting 300 million people53
worldwide [8]. In the UK, 3-4 million currently suffer from advanced periodontitis at a cost of54
£2 billion/year to the National Health Service (NHS). Associations have emerged between55
periodontitis and a growing list of chronic conditions including atherosclerosis, diabetes and56
RA [9-11].57
The links between rheumatoid arthritis and periodontal disease.58
RA and periodontitis display some pathogenic similarities, such as the host immune59
response leading to soft tissue inflammation with subsequent hard tissue destruction, and60
certain risk factors, including smoking and excess weight or obesity, although some studies61
only show associations at specific stages of disease aetiology [12-17]. The significant RA62
ULVNDWWULEXWHGWRWKHVKDUHGHSLWRSH+/$'5ȕ6(LVZHOOHVWDEOLVKHG>@EXWDVVRFLDWLRQV63
of specific human leukocyte antigen (HLA) molecules with chronic periodontitis are unclear.64
4Multiple studies have shown an epidemiological association between periodontitis and RA65
and these have been reviewed recently [6, 19, 20]. Inconsistent diagnosis of periodontal66
disease may have led to an alternative conclusion in some studies [6, 21]. However, a67
systematic review and meta-analysis confirmed an elevated risk of periodontitis in RA68
patients compared with healthy controls [19]. Analyses of detailed clinical data have69
revealed significantly raised indicators of the severity of periodontal disease (mean probing70
depth; bleeding on probing, BOP; absolute clinical attachment loss, CAL; tooth loss) in71
people with RA compared to those without [19, 22].72
Understanding the common mechanisms that underlie periodontitis and RA could present73
new possibilities for the treatment and prevention of RA. The link between these conditions74
was further highlighted in a recent study where patients with periodontitis and arthralgia who75
later developed RA had higher levels of disease activity and were more likely to receive76
methotrexate at RA diagnosis compared to patients without periodontitis [23].77
Periodontal diseases78
Periodontal diseases are complex polymicrobial conditions resulting from an imbalance79
between the resident subgingival microbial communities, which grow as biofilms adhered to80
the tooth and tissue surfaces, and host responses to them. In these dysbiotic diseases,81
damage to the supporting tissues of the teeth occurs because the immune system fails to82
control both the microbial communities and the local host immune response to them [24].83
The term, periodontal disease, describes a spectrum of inflammatory conditions. Gingivitis84
is an inflammatory response to the accumulation of dental plaque at the gingival margin85
(Figure). It is reversible and can be eradicated by maintaining good oral hygiene.86
Conversely, the damage associated with periodontitis is irreversible; chronic inflammation87
within the supporting tissues of the teeth (Figure) and the consequent tissue destruction and88
5gingival epithelial migration cause progressive attachment loss and bone loss, characterised89
by periodontal pocket formation and/or gingival recession [25].90
The most common form of periodontitis is chronic adult periodontitis, which is assessed as91
mild, moderate or severe/advanced depending on the extent of BOP, periodontal pocket92
formation, radiographic bone loss and CAL [25]. Aggressive periodontitis is a less common,93
severe form of the disease which often occurs in people under 25 years. It may be localised94
to certain teeth or generalised, and can be associated with a more sparse plaque than that95
observed in chronic adult periodontitis. Two RA-associated genes that function in96
,QWHUIHURQȕ,)1ȕVLJQDOOLQJZHUHKLJKOLJKWHGLQFDVHVRIDJJUHVVLYHSHULRGRQWLWLVDVVKDUHG97
susceptibility factors, but the aetiologies of aggressive and chronic periodontitis differ and the98
genetic contribution may be lesser in chronic periodontitis [26, 27].99
The microbiology of periodontal diseases100
Periodontal pockets can reach a probing depth of up to 12mm; this stagnant and anaerobic101
site may harbour up to 108 diverse bacteria [28]. More than 700 bacterial species have102
been identified from the human mouth; only about 60% of these can currently be cultured in103
the laboratory [29], so nucleic acid based methodologies are essential to understand the104
entirety of the health and disease-associated microbiota. It is important to recognise that105
periodontitis is a polymicrobial infection caused by co-operating consortia of organisms [30].106
Organisms associated with severe periodontitis are often also isolated from healthy sites,107
albeit in low numbers; pathogenic communities arise from the normal microbiota through108
processes of selection in response to local environmental pressures that are associated with109
inflammation and bleeding, and through the failure of the host responses to control the110
subgingival microbiota [31, 32]. As periodontitis develops, there is a transition from plaque111
6dominated by Gram-positive facultatively anaerobic species, to communities that are112
dominated by obligately anaerobic, proteolytic Gram-negative rods and spirochaetes [32].113
Many organisms increase in abundance with the development of periodontitis, and newly114
described potential pathogens are emerging [32, 33]. Porphyromonas gingivalis may115
function as a “keystone pathogen” in chronic periodontitis, playing a disproportionately116
important role by depressing and deregulating local immune responses, increasing the117
virulence of the whole community and promoting the dysbiosis that is characteristic of118
periodontitis [30]. It is in turn dependent on the activities of accompanying accessory119
organisms (e.g. Streptococcus gordonii) to express its full pathogenicity [34].120
Aggregatibacter actinomycetemcomitans is associated with localised aggressive periodontitis121
(LAP), in which it may function as a keystone pathogen [35, 36]; a combination of A.122
actinomycetemcomitans, Filifactor alocis and Streptococcus parasanguinis was highly123
predictive of bone loss in individuals susceptible to LAP [35]. Viruses are only rarely124
considered, but they may also play a role in development of periodontitis [37].125
Oral host-microbe homeostasis is maintained by the constant control of the microbial burden126
and protection mediated by inflammatory and immune defences. Periodontal pathogens127
manipulate, dysregulate and subvert these defence mechanisms, disabling protective128
mechanisms and disrupting control of the microbiota. Inflammophilic species, such as P.129
gingivalis, dysregulate processes to drive inflammation and elicit tissue damage, yielding a130
supply of nutrients to support their survival.131
The roles of host defences132
Both innate and adaptive immune functions are important to the development of periodontitis.133
It is beyond the scope of this review to discuss all immune contributions to the disease in134
detail but they have been extensively reviewed recently [38, 39].135
7The chronic nature of inflammation in periodontitis allows for substantial lymphocyte136
involvement, including significant B and CD4+ T cell infiltration into gingival tissues and137
LQFUHDVHGH[SUHVVLRQRI7KDQG7KF\WRNLQHVDQGUHFHSWRUDFWLYDWRURIQXFOHDUIDFWRUț%138
ligand (RANKL). RANKL stimulates osteoclastogenesis and subsequent resorption of139
DOYHRODUERQH>@  ([SUHVVLRQRIJHQHVHQFRGLQJ,/ȕ,/,/VXSSRUWLQJ7K140
differentiation) have been detected in diseased gingival tissue, in addition to IL-23-producing141
macrophages that amplify Th17 responses [40]. Increases in Th17 cells in the synovium of142
RA joints have also been reported [39]. In periodontitis, elevated IL-17 levels may143
perpetuate phagocyte recruitment and induce osteoclastic differentiation of monocytes [38,144
40, 41]. A counterbalance to Th1 and Th17 CD4 T cell activity may be provided by CD4145
75HJFHOOVE\VHFUHWLRQRILPPXQRVXSSUHVVLYH,/DQG7*)ȕEXWHYLGHQFHIRUWKHUROHRI146
IL-10 in periodontal health/disease is equivocal [40].147
Innate immunity is involved from the early stages of periodontal disease. Some periodontal148
bacteria dysregulate the functions of Toll-like receptors (TLRs) expressed by cells in gingival149
tissues, leading to tissue damage and periodontal disease pathogenesis [24]. Complement150
is vital, both early in the development of dysbiosis and in driving the inflammatory destruction151
of periodontal tissue, and the alternative pathway of complement activation predominates in152
periodontitis [42]. Some bacteria (e.g. P. gingivalis, F. alocis, Prevotella intermedia,153
Treponema denticola, Tannerella forsythia) manipulate the complement system, e.g. through154
binding and/or proteolytic cleavage of endogenous inhibitors, C3 convertase or C5 while155
allowing release of anaphylatoxin C5a. These strategies allow bacteria to evade156
complement-mediated microbicidal activities, while promoting inflammation and neutrophil157
recruitment to the periodontal pocket.158
Neutrophils are of primary importance in the maintenance of gingival homeostasis [43]. In159
health, resident bacteria stimulate gingival epithelial cells to establish a CXCL-8 chemotactic160
8gradient and upregulate expression of the neutrophil chemotactic receptor, CXCR-2, thereby161
promoting neutrophil homing to periodontal tissue and their formation into a protective barrier162
between the biofilm and host [44]. Neutrophils account for 90% of the leucocytes in gingival163
crevicular fluid (GCF) and their concentration increases 15-fold in periodontally diseased164
sites [45]. Their fundamental protective role is illustrated by the often severe periodontitis165
associated with iatrogenic neutropenia and with inherited dysfunctions in neutrophil effector166
functions, e.g. Chediak-Higashi and Papillon Lefevre syndromes. Impaired neutrophil167
chemotaxis has been reported in periodontitis and periodontal pathogens employ various168
strategies to disrupt neutrophil chemotaxis and/or function [39, 42, 46].169
The neutrophil antimicrobial arsenal includes the generation of reactive oxygen species170
(ROS), the release of granule contents which include matrix metalloproteinase 8, gelatinases,171
myeloperoxidase (MPO), neutrophil serine proteases and antimicrobial peptides such as172
ĮGHIHQVLQVDQGK&$3WKH//SUHFXUVRU  1HXWURSKLOVJHQHUDWH1HXWURSKLO173
Extracellular Traps (NETs), decondensed webs of chromatin that are decorated with174
antimicrobial proteins derived from neutrophil granules. A widely held view is that NET175
generation is facilitated by NADPH oxidase, neutrophil elastase and peptidyl arginine176
deiminase 4 (PAD4); PAD4 converts positively charged arginine residues within histone177
proteins into neutral citrulline, thereby disrupting electrostatic interactions and inducing178
chromatin decondensation [46, 47]. Increased NET production, or impeded NET clearance,179
may contribute to inflammatory responses as NETs provide an extracellular reservoir of180
inflammatory components, such as LL-37, bacterial components, ds-DNA and181
hypercitrullinated proteins. PAD4-/- mice are more susceptible to bacterial infections and182
NETs have been detected in the GCF from periodontal disease sites in abundance [47].183
9In addition to their importance in periodontal diseases, neutrophils and periodontal bacteria184
have been implicated in mechanisms that increase the generation of autoantibodies that are185
important in the development of RA.186
Autoantibodies in RA and periodontal disease.187
The importance in RA of autoantibodies against proteins that have undergone188
post-translational modification (PTM) has been extensively reviewed recently [1-3]. Some189
of these antibodies have also been observed in periodontal tissues and disease [26, 48].190
Citrullination, a PTM of arginine, is involved in the formation of hair, skin, myelin sheaths, in191
NET formation and inflammation, and in cell death [1]. It is mediated by PAD enzymes, of192
which there are five in humans [49]. Citrullination alters tertiary protein structure and193
function and may expose previously hidden immune epitopes [50]. Neutrophils are enriched194
for PADs and calcium-associated hyper-activation of neutrophil PADs leads to195
hypercitrullination of proteins [49]. However, there is an active debate concerning the196
methods employed to study NETosis, the roles of PADs and the routes to protein197
hypercitrullination, with the proposal that exposure of neutrophils to bacterial pore-forming198
toxins, complement membrane attack complex (MAC) or perforin leads to generation of199
NET-like structures and a process of leukotoxic hypercitrullination [49].200
Serum anti-citrullinated protein antibodies (ACPAs) are present in 70% of RA patients; they201
are associated with RA progression and may be detectable up to 10 years before the onset of202
clinical disease [48]. Citrullinated proteins have been detected in periodontal tissues [51, 52]203
and there are significant associations between ACPA seropositivity and periodontal disease204
[53, 54]. Therefore, a popular hypothesis is that in genetically susceptible individuals,205
citrullination associated with periodontitis may cause a localised oral mucosal immune206
response, which can lead to a systemic ACPA response, followed by synovial inflammation207
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and the onset of RA [55]. However, Konig et al. have challenged the hypothesised central208
role for autoantibodies against citrullinated proteins in the loss of tolerance in RA209
development, asserting the importance of antibodies against native unmodified proteins as210
the driving force behind loss of immune tolerance, preceding development of ACPAs [56].211
Carbamylation is a non-enzymatic PTM in which cyanate binds to the primary amine of lysine212
and forms carbamyl groups, generating peptidyl-homocitrulline against which autoantibodies213
(anti-CarP) are generated [2]. Neutrophil MPO can enhance protein carbamylation by214
promoting generation of cyanate from thiocyanate [57]. Like citrullination, carbamylation215
may affect protein function, e.g. carbamylation of immunoglobulin G (IgG) can inhibit216
classical complement pathway activation [58]. Anti-CarP have been detected in217
ACPA-negative and ACPA-positive pre-RA and established RA patients [59, 60], and were218
predictive of the development of RA independently of anti–CCP2 (citrullinated cyclic peptide219
2) antibodies [61]. In ACPA-negative patients, anti-CarP antibodies are predictive of a more220
severe RA disease course [62]. However, there were no significant associations between221
anti-CarP and RA genetic risk factors or smoking, suggesting anti-CarP antibody formation222
occurs via different biological mechanisms to ACPA formation [63]. A recent study detected223
a weak association between ACPA seropositivity and periodontitis but there was none224
between periodontitis and anti-carP seropositivity [53], although carbamylated proteins were225
detected in inflamed gingival tissues [48] and MPO was elevated in periodontitis [64, 65].226
Antibodies against proteins modified with malondialdehyde-acetaldehyde adducts (MAA)227
were increased in established RA patients and were associated with ACPA and RF detection228
[66]. MAA are generated when lipid peroxidation by ROS (produced during oxidative stress229
and released from neutrophils) forms highly reactive malondialdehyde and acetaldehyde230
molecules, which modify lysine residues of proteins to generate stable MAA [67].231
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Preliminary data indicate injection of mice with P. gingivalis could increase production of232
MAA antibodies [68].233
Porphyromonas gingivalis, RA and autoantibody production234
P. gingivalis expresses several virulence factors, such as fimbriae, lipopolysaccharide,235
capsular polysaccharide and cysteine proteases (gingipains). These collectively contribute236
to its ability to colonise, invade and damage host tissues, and also to degrade and237
dysregulate local immune responses [43]. The arginine-specific (RgpA and RgpB) and238
lysine-specific (Kgp) gingipains are crucial for P. gingivalis survival and growth in the239
anaerobic periodontal pocket [69] and they are fundamental to its ability to manipulate host240
immune responses [70, 71].241
P. gingivalis also produces a peptidyl-arginine deiminase (PPAD) capable of citrullinating242
host and bacterial proteins, but which has no sequence homology with human PADs [72].243
Unlike human PADs, PPAD preferentially citrullinates terminal arginines and also free244
arginine, and works best at the slightly alkaline pH that is optimal for P. gingivalis growth [72,245
73]. Rgp gingipains cleave polypeptide chains at internal arginine residues, generating246
peptides with terminal arginines that are susceptible to PPAD citrullination [74]. PPAD247
activity has been detected in GCF from periodontitis patients and at lower levels in healthy248
controls [75]. It is capable of auto-citrullinating some of its 18 arginine residues [76],249
although there is evidence that anti-PPAD antibodies are not directed against the citrullinated250
form of PPAD and that in humans, PPAD is not modified in this manner [77]. PPAD251
enhances cell invasion by P. gingivalis [78] and citrullinates host defence components, such252
as complement and LL-37, with consequent loss of function [79, 80]. Human fibrinogen and253
ĮHQRODVHWZRRIWKHSURWHLQVWDUJHWHGE\$&3$VLQ5$>@DUHDOVR33$'VXEVWUDWHVDQG254
12
antibodies against auto-citrullinated P. gingivalisHQRODVHFURVVUHDFWZLWKKXPDQĮHQRODVH255
autoantibodies [48].256
Animal model studies support the hypothesis that P. gingivalis is important in the aetiology of257
RA. P. gingivalis expressing PPAD accelerated progression and enhanced severity of258
collagen-induced arthritis in mice and was associated with higher levels of citrullinated259
proteins at diseased sites [81]. Exposure to P. gingivalis in mice expressing human260
+/$'5ȕLPSDLUHGUHVLVWDQFHWRWKHGHYHORSPHQWRIDUWKULWLVDQGLQGXFHGDXWRLPPXQH261
arthritis, and generated increased Th17 cell frequency, systemic cytokine activity and ACPA;262
both PPAD and the HLA-DR1 restriction were needed to drive ACPA generation [82].263
Epidemiological studies of the associations between P. gingivalis, PPAD or Rgp and RA264
(including pre-RA) have been equivocal. DNA from P. gingivalis was detected in synovial265
fluid of RA patients more often than in controls [83] and more often in the GCF of RA patients266
compared with controls [75]. Although one study found no increase in anti-RgpB antibodies267
in RA sera [76], another found that anti-RgpB antibody levels were significantly elevated in268
ACPA-positive RA patients compared with ACPA-negative, and the significant association269
between anti-RgpB IgG and RA was stronger than that between smoking and RA [84].270
There are conflicting data and opinions regarding the relationship of PPAD with RA.271
Elevated PPAD activity in GCF was not clearly associated with RA even though P. gingivalis272
detection in GCF was [75]. While one study found anti-PPAD antibodies were elevated in273
RA sera compared with sera from controls [76], another found anti-PPAD antibodies did not274
correlate with ACPA levels or RA disease activity and levels were decreased in RA patients275
with PD [77]. Methodological differences have been suggested to account for this276
discrepancy [85]. A recent study of RA patients on disease-modifying anti-rheumatic drug277
(DMARD) therapy, found a correlation between anti-PPAD IgG and anti-CCP IgG, both of278
which were significantly increased in the RA group compared with controls [86]. RA patients279
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treated with biological DMARDs who had low anti-PPAD IgG titres showed a significantly280
greater decrease in RA disease activity score compared with patients with high anti-PPAD281
IgG titres, indicating that serum IgG anti-PPAD may be useful as a predictive biomarker for282
response to RA therapy [87].283
Most studies have focused on patients with established RA; to better understand284
pathogenesis and develop therapies it is important to also investigate individuals at risk for285
the development of RA. An increased concentration of anti-P. gingivalis antibodies has286
been reported in individuals at genetic risk of developing RA (some also had RA-related287
autoantibodies) [88]. Furthermore, higher anti-RgpB IgG levels were found in the blood of288
pre-RA and established RA individuals compared with healthy controls; while ACPA levels289
increased with time, anti-RgpB antibody levels did not and they decreased following290
diagnosis [89]. In contrast, no association between anti-RgpB and pre-RA was found in a291
different study of a Southern European cohort [14]. Importantly, these studies did not292
evaluate clinical periodontal status alongside P. gingivalis antibody levels. In a recent study293
of an early inflammatory arthritis cohort, periodontitis, but not the subgingival presence of P.294
gingivalis, was more enriched in patients who later progressed to classifiable RA [23].295
Similarly, De Smit et al concluded that, while there was evidence that periodontal disease296
may precede symptomatic RA, there was insufficient evidence to confirm a role specifically297
for P. gingivalis in disease progression [90].298
Thus, while the link between periodontitis and RA is established, the specific roles of P.299
gingivalis or PPAD are less clear. This could partly be due to strain-to-strain differences,300
although it is not yet known if there is any difference in the activity of PPAD from different P.301
gingivalis strains/genotypes. Five distinct rgpB genotypes have been found in clinical P.302
gingivalis isolates and the activity of the expressed gingipains would impact on that of PPAD303
[91]. The activities of other bacteria in the subgingival community may also be influential;304
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although P. gingivalis is a “keystone pathogen” that increases the risk of periodontitis, it305
depends upon the activities of other members of the microbiota to colonise, grow, invade306
epithelial cells and express its full virulence [34].307
Multiple mechanisms may be important308
Periodontitis is a complex disease, mediated by consortia of co-operating bacteria and the309
host responses to them. It is, therefore, logical to widen consideration of the influence of the310
microbiota beyond that of a single, albeit important, bacterium. For example, the leukotoxin311
produced by A. actinomycetemcomitans has been implicated in inducing leukotoxic312
hypercitrullination, and exposure to A. actinomycetemcomitans was associated with ACPA313
and rheumatoid factor (RF) [92]. The subgingival microbiota of periodontitis is enriched for314
obligately anaerobic proteolytic bacteria [32] and they may contribute alongside P. gingivalis315
to the enzymatic cleavage of host proteins, particularly components of the extracellular matrix,316
and enhanced generation of neo-epitopes [93, 94]. Using 16S rRNA sequence analysis of317
the entire subgingival microbiome, Scher et al. found that the microbiome of RA patients was318
similar to healthy subjects with similar periodontal status, but, specific Prevotella and319
Leptotrichia operational taxonomic units (OTUs) were only found in new-onset RA patients,320
and Anaeroglobus geminatus was correlated with the presence of ACPA and RF, and with321
periodontitis [95]. Another large-scale study using metagenomic shotgun sequencing322
identified compositional and functional alterations in RA-associated oral microbiomes, which323
were partly resolved by DMARD treatment; thus, this big data approach suggests that324
microbiome composition could be important in prognosis and diagnosis of RA [96].325
Neutrophils are key players in both RA and periodontitis. They can promote autoantibody326
production by multiple routes, all of which may be important in RA, and they also contribute to327
the immune dysregulation and tissue damage associated with periodontitis. Interference328
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with the normal functions of neutrophils is an important pathogenic strategy employed by329
many periodontal bacteria and some of these may in turn promote neutrophil mediated330
autoantibody production; e.g. the pore-forming leukotoxin of A. actinomycetemcomitans [49];331
F. alocis promotion of neutrophil degranulation [97]; P. gingivalis, A. actinomycetemcomitans332
and F. nucleatum triggering the release of NETs [47].333
While local responses are important, systemic influences on blood should be considered.334
Peripheral blood neutrophils in patients with inflammatory diseases such as periodontitis and335
RA have been reported to display an activated phenotype with hyperactive respiratory burst336
responses and, in RA, increased NETosis [47, 98, 99]. Oral bacteria regularly gain access337
to the blood and have been detected at distant sites such as the heart and also in synovial338
tissue samples [100]. Pretorius et al. have proposed that an aberrant blood microbiome339
may play a significant role in the aetiology of RA [101] and other systemic diseases that have340
been linked to periodontitis [102]. Microscopic analysis of blood from periodontitis patients341
revealed bacteria associated with erythrocytes at a much higher prevalence than seen in342
blood from healthy controls [102]. In this analysis, bacteria that gain ingress into the blood343
may remain dormant, most likely because they are deprived of essential iron; dormant344
bacteria are associated with circulating cells including erythrocytes and in this state they may345
constitute a persistent supply of inflammatory molecules including lipopolysaccharide. The346
authors propose this may be a unifying principle underlying the links between inflammatory347
diseases such as periodontitis and a range of systemic diseases including RA.348
349
Practice points:350
The association between RA and periodontitis indicates the potential benefits of the closer351
integration of medical and dental care:352
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x RA patients have an increased prevalence of periodontal disease and therefore353
should be encouraged to have regular dental assessments354
x Periodontal disease may be associated with increased RA disease activity; if355
periodontal disease is identified in a patient with RA it should be managed by a dentist356
x Individuals at heightened risk for RA (e.g. first degree relatives of RA patients) may357
benefit from regular dental assessments and early treatment of periodontal disease,358
in addition to other lifestyle interventions (eg smoking cessation)359
Research agenda:360
It is essential to fully understand the pathophysiology of both RA and periodontitis to361
understand the inter-relationship between the two diseases and to find novel predictive362
markers of RA disease activity and progression. Some individual organisms such as P.363
gingivalis and A. actinomycetemcomitans are important but it is essential to consider the364
roles of imbalances of the composition and functions of the entire subgingival microbiome365
and, potentially, the blood microbiome. Further fundamental and translational research is366
required:367
x To determine the influence of periodontal disease on the initiation and propagation of368
RA-autoimmunity. This will be best investigated in prospective cohorts of at-risk369
individuals including those with genetic risk (FDRs) and those with systemic370
autoimmunity371
x To better understand the role of specific organisms such as P. gingivalis and A.372
actinomycetemcomitans as well as the entire subgingival microbiome in the373
development of localized and systemic RA-autoimmunity. To determine which374
organisms are associated with progression along the continuum from Pre-RA to375
established RA.376
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x To determine whether periodontal treatment should be considered as an adjunct to377
immunotherapy in patients with early RA.378
x To conduct clinical trials to address whether treatment of periodontal disease and/or379
manipulation of the subgingival microbiome can delay or prevent RA in at-risk380
individuals.381
382
Summary383
Multiple studies have shown an epidemiological association between periodontitis and RA.384
Specific periodontal pathogens, P. gingivalis or A. actinomycetemcomitans, have been385
hypothesised to be of particular importance because they possess virulence determinants386
(PPAD and leukotoxin, respectively) that can contribute to the generation of citrullinated387
proteins and potentially trigger development of RA-related autoantibodies. However,388
periodontitis is a complex disease, mediated by consortia of co-operating bacteria and the389
host responses to them. Multiple mechanisms are likely to contribute to the association390
between periodontitis and RA and it is essential to consider the roles of imbalances of the391
composition and functions of the entire subgingival microbiome. Subgingival bacteria may392
contribute directly through enzymatic modification of proteins and subsequent autoantibody393
generation, or indirectly by dysregulation of neutrophils and enhancement of those neutrophil394
activities that contribute both to neo-epitope generation and host-mediated damage to395
periodontal tissues. It is possible that periodontal bacteria in the blood and hyper-active396
peripheral blood neutrophils may play a part in loss of immune tolerance and development of397
RA. Understanding the mechanisms underlying the inter-relationship between the two398
diseases and the influence of periodontitis and the periodontal microbiome on the initiation399
and propagation of RA-autoimmunity may help to identify novel predictive markers in400
individuals at risk of RA; it will inform clinical trials to determine if periodontal therapy should401
18
be considered as an adjunct to immunotherapy in patients with early RA and whether402
treatment of periodontal disease and/or manipulation of the subgingival microbiome can403
delay or prevent RA in at-risk individuals.404
405
406
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